President Trump Delivers an Announcement, Sep. 30, 2025

*TRUMP: PFIZER AGREED TO OFFER MEDICATIONS AT MAJOR DISCOUNTS *TRUMP: WE'RE GOING TO BE PAYING THE LOWEST PRICE *TRUMP: US WILL BE PAYING MOST FAVORED NATIONS PRICE TRUMP: US CONSUMERS HAVE BEEN SUBSIDISING R&D COSTS TRUMP: DRUGS WILL BE AVAILABLE THROUGH GOVERNMENT WEBSITE

*TRUMP: WILL TARIFF DRUG COMOPANIES THAT DON'T MAKE A DEAL *TRUMP: WILL TARIFF PHARMA COMPANIES EXTRA 5% TO 8% IF NO DEALS Fact Sheet: President Donald J. Trump Announces First Deal to Bring Most-Favored-Nation Pricing to American Patients Today, President Donald J. Trump announced the first agreement with a major pharmaceutical company, Pfizer, to bring American drug prices in line with the lowest paid by other developed nations (known as the most-favored-nation, or MFN, price). • The agreement will provide every State Medicaid program in the country access to MFN drug prices on Pfizer products, resulting in many millions of dollars in savings and continuing President Trump’s historic efforts to strengthen the program for the most vulnerable. • The agreement ensures foreign nations can no longer use price controls to freeride on American innovation by guaranteeing MFN prices on all new innovative medicines Pfizer brings to market. • The agreement requires Pfizer to repatriate increased foreign revenue on existing products that Pfizer realizes as a result of the President’s strong America First U.S. trade policies for the benefit of American patients. The agreement requires Pfizer to offer medicines at a deep discount off the list price when selling directly to American patients.

The number of job openings was unchanged at 7.2 million in August, the U.S. Bureau of Labor Statistics reported today. Over the month, both hires and total separations were little changed at 5.1 million. Within separations, both quits (3.1 million) and layoffs and discharges (1.7 million) were little changed. This release includes estimates of the number ...